Aligos Therapeutics Grants Stock Options to New Employees Under Inducement Plan
Aligos Therapeutics Inc. has granted non-qualified stock options to purchase 23,600 shares to new employees under its 2024 Inducement Plan. The options have an exercise price set at the closing price of Aligos' common stock on November 11, 2025, and will vest over four years. This news was originally published by Aligos Therapeutics via GlobeNewswire on November 14, 2025.
Aligos Therapeutics Inc. has granted non-qualified stock options to purchase a total of 23,600 shares to newly hired employees. These options were awarded under the company’s 2024 Inducement Plan. The exercise price for the options is set at the closing price of Aligos’ common stock on the grant date of November 11, 2025. Vesting for these options will occur over four years, with 25% vesting after the first year and the remaining shares vesting in equal monthly installments, contingent on continued employment. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aligos Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9573396-en) on November 14, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
